Establishing Preclinical Proof-of-Concept of Gene Therapy for Huntington Disease

被引：0
|
作者：
Evers, Melvin [1 ]
机构：
[1] UniQure, Res, Amsterdam, Netherlands
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S30.002
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EOFAD: OPPORTUNITIES FOR PROOF-OF-CONCEPT STUDIES TO MODIFY DISEASE PROGRESSSION
    Gauthier, Serge
    Rosa-Neto, P.
    [J]. NEUROBIOLOGY OF AGING, 2012, 33 : S12 - S12
  • [42] RNAi: From Concept to Human Proof-of-Concept
    Vaishnaw, Akshay
    Nochur, Sara
    Ftizgerlad, Kevin
    Simon, Amy
    Gollob, Jared
    [J]. NUCLEIC ACID THERAPEUTICS, 2012, 22 (06) : A12 - A12
  • [43] A novel therapeutic strategy for skeletal disorders: proof-of-concept of gene therapy for X-linked hypophosphatemia
    Jauze, L.
    Zhukouskaya, V. V.
    Charles, S.
    Leborgne, C.
    Hilliquin, S.
    Sadoine, J.
    Slimani, L.
    Baroukh, B.
    van Wittenberghe, L.
    Daniele, N.
    Rajas, F.
    Linglart, A.
    Mingozzi, F.
    Chaussain, C.
    Bardet, C.
    Ronzitti, G.
    [J]. HUMAN GENE THERAPY, 2021, 32 (19-20) : A103 - A103
  • [44] PROOF-OF-CONCEPT STUDY TESTING SOM3355, A VMAT2 INHIBITOR FOR THE TREATMENT OF CHOREA IN HUNTINGTON'S DISEASE
    Gamez, Josep
    Calopa, Matilde
    Munoz, Esteban
    Ferre, Aileen
    Huertas, Oscar
    McAllister, Kevin
    Reig, Nuria
    Scart-Gres, Catherine
    Insa, Raul
    Kulisevsky, Jaime
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 : A35 - A36
  • [45] Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models
    Toledo-Sherman, Leticia
    Breccia, Perla
    Cachope, Roger
    Bate, Jennifer R.
    Angulo-Herrera, Ivan
    Wishart, Grant
    Matthews, Kim L.
    Martin, Sarah L.
    Cox, Helen C.
    McAllister, George
    Penrose, Stephen D.
    Vater, Huw
    Esmieu, William
    Van de Poel, Amanda
    Van de Bospoort, Rhea
    Strijbosch, Annelieke
    Lamers, Marieke
    Leonard, Philip
    Jarvis, Rebecca E.
    Blackaby, Wesley
    Barnes, Karen
    Eznarriaga, Maria
    Dowler, Simon
    Smith, Graham D.
    Fischer, David F.
    Lazari, Ovadia
    Yates, Dawn
    Rose, Mark
    Jang, Sung-Wook
    Munoz-Sanjuan, Ignacio
    Dominguez, Celia
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (06) : 2988 - 3008
  • [46] Modification of gene expression using topical antioxidant: A proof-of-concept study
    Brody, Neil
    Shagalov, Devorah
    Fiadorchanka, Natallia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB193 - AB193
  • [47] Topically applied NanoFlares to measure gene expression in vivo: Proof-of-concept
    Paller, A. S.
    Yeo, D.
    Wiraja, C.
    Mirkin, C.
    Xu, C.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S180 - S180
  • [48] Targeting a6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models
    Lee, Ming Tatt
    Mouri, Akihiro
    Kubota, Hisayoshi
    Lee, Hsin-Jung
    Chang, Man-Hsin
    Wu, Chen-Yi
    Knutson, Daniel E.
    Mihovilovic, Marko
    Cook, James
    Sieghart, Werner
    Nabeshima, Toshitaka
    Chiou, Lih-Chu
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
  • [49] Stem cell therapy in cats with chronic enteropathy: a proof-of-concept study
    Webb, Tracy L.
    Webb, Craig B.
    [J]. JOURNAL OF FELINE MEDICINE AND SURGERY, 2015, 17 (10) : 901 - 908
  • [50] Massage therapy for hospital-based nurses: A proof-of-concept study
    Hulett, Jennifer M.
    Spotts, Ruth Anne
    Narkthong, Natsayakarn
    Scott, Susan D.
    [J]. COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2024, 55
12345